🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for BCLC Stage C Hepatocellular Carcinoma

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy NCT07436845n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC NCT06172205Phase 31 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: intravenous FOLFOX7 plus Camrelizumab and apatinib, HAIC-FOLFOX plus Camrelizumab and apatinib Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion NCT05992220Phase 21 site📍 Seoul Asan Medical Center · Tests: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion, Atezolizumab plus bevacizumab BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases NCT07062055Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Anti-VEGF, Immunotherapy, Local Therapy, hepatic arterial infusion chemotherapy (HAIC), Surgical Resection Liver Cancer and Immunotherapy in the Liquid Biopsy Era NCT05810402NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Liquid Biopsy Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC NCT06999694Phase 21 site📍 Taoyuan City Chang Gung Memorial Hospital · Tests: Proton radiotherapy, Tremelimumab, Durvalumab Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC NCT06999707Phase 21 site📍 Taoyuan City Chang Gung Memorial Hospital · Tests: Photon radiotherapy, Tremelimumab, Durvalumab HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC NCT06632093n/a1 site📍 Shenyang First Hospital of China Medical University · Tests: hepatic artery infusion chemotherapy, Lenvatinib + PD-1 monoclonal antibody
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy